[go: up one dir, main page]

AU2001288792A1 - Method of treating neurologic disorders - Google Patents

Method of treating neurologic disorders

Info

Publication number
AU2001288792A1
AU2001288792A1 AU2001288792A AU8879201A AU2001288792A1 AU 2001288792 A1 AU2001288792 A1 AU 2001288792A1 AU 2001288792 A AU2001288792 A AU 2001288792A AU 8879201 A AU8879201 A AU 8879201A AU 2001288792 A1 AU2001288792 A1 AU 2001288792A1
Authority
AU
Australia
Prior art keywords
neurologic disorders
treating neurologic
treating
disorders
neurologic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001288792A
Inventor
Ian D. Duncan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
NEUROTHERAPEUTICS LLC
Original Assignee
NEUROTHERAPEUTICS LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by NEUROTHERAPEUTICS LLC filed Critical NEUROTHERAPEUTICS LLC
Publication of AU2001288792A1 publication Critical patent/AU2001288792A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/65—Tetracyclines

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2001288792A 2000-09-06 2001-09-06 Method of treating neurologic disorders Abandoned AU2001288792A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US23035000P 2000-09-06 2000-09-06
US60230350 2000-09-06
PCT/US2001/027593 WO2002020022A1 (en) 2000-09-06 2001-09-06 Method of treating neurologic disorders

Publications (1)

Publication Number Publication Date
AU2001288792A1 true AU2001288792A1 (en) 2002-03-22

Family

ID=22864879

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001288792A Abandoned AU2001288792A1 (en) 2000-09-06 2001-09-06 Method of treating neurologic disorders

Country Status (3)

Country Link
US (1) US20030203881A1 (en)
AU (1) AU2001288792A1 (en)
WO (1) WO2002020022A1 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003005971A2 (en) 2001-07-13 2003-01-23 Paratek Pharmaceuticals, Inc. Tetracycline compounds having target therapeutic activities
US20040110691A1 (en) * 2001-11-13 2004-06-10 Stamler Jonathan S. Thiol reactive agents as a therapeutic modality
EP1558268A4 (en) * 2002-09-17 2008-09-17 Univ New York METHOD FOR TREATING AGE ASSOCIATED MEMORY DISORDERS (AAMI), EASY COGNITIVE IMPAIRMENT (MCI), AND CELL CYCLIC DISEASES
MXPA05009134A (en) * 2003-02-26 2005-12-05 Johns Hopkins Universty Glutamate transport modulatory compounds and methods.
WO2005041978A1 (en) * 2003-10-21 2005-05-12 Johns Hopkins University Neuroprotection with beta-lactam compounds
US20070066572A1 (en) * 2005-09-14 2007-03-22 Kalyanaraman Balaraman Neuroprotection by positively-charged nitroxides
HUP0800414A2 (en) * 2008-07-04 2010-10-28 Pecsi Tudomanyegyetem Pharmaceutical combination
EP2307027A4 (en) 2008-07-11 2012-08-15 Neumedics Tetracycline derivatives with reduced antibiotic activity and neuroprotective benefits
US20150174144A1 (en) * 2012-07-13 2015-06-25 Paratek Pharmaceuticals, Inc. Tetracycline compounds for treating neurodegenerative disorders
EP3946290A4 (en) * 2019-04-04 2022-12-21 CMTX Biotech Inc. METHODS OF TREATING CHARCOT-MARIE-TOOTH DISEASE
FR3099697B1 (en) * 2019-08-09 2022-07-08 Soc Dexploitation De Produits Pour Les Industries Chimiques Seppic Pharmaceutical composition for topical use in the form of a dispersed phase based on at least one short diol in a continuous fatty phase and comprising at least one anti-inflammatory substance.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5789395A (en) * 1996-08-30 1998-08-04 The Research Foundation Of State University Of New York Method of using tetracycline compounds for inhibition of endogenous nitric oxide production
US6803233B2 (en) * 2000-07-31 2004-10-12 The Regents Of The University Of California Model for Alzheimer's disease and other neurodegenerative diseases

Also Published As

Publication number Publication date
WO2002020022B1 (en) 2002-07-11
WO2002020022A1 (en) 2002-03-14
US20030203881A1 (en) 2003-10-30

Similar Documents

Publication Publication Date Title
AU2001285159A1 (en) Methods for treating endocrine disorders
AU2001238472A1 (en) Method for treating parathyroid disorders
AU7085100A (en) Method for treating otic disorders
AU2002243231A1 (en) Method of treating autoimmune diseases
HUP0200495A3 (en) Method of treating eating disorders
AU3977700A (en) Method of treating neurological disorders
AU2001286983A1 (en) Method of treatment
AU2001240046A1 (en) Method of treating skin conditions
AU5042000A (en) Methods of treating proliferative disorders
AU2001288792A1 (en) Method of treating neurologic disorders
AU2001232263A1 (en) Method of treating seeds
AU2002365814A1 (en) Method of treating asthma
AU4552200A (en) Method of treating psychotic disorders
AU8333701A (en) Method of treating angiogenesis-related disorders
AU3757300A (en) Method of treating anxiety disorders
AU2001253836A1 (en) Method of treating cancer
AU1133901A (en) Method of treating metabolic disorders
AU1735800A (en) Method of treating seizure disorders
AU2001262177A1 (en) Method of treatment
AU3753500A (en) Methods of treating fibrinogen-related disorders
AU2599399A (en) Method of treating migraine
AU2002229795A1 (en) Method for treating sexual disorders
AU2001236909A1 (en) Method of treating disorders of the eye
AU8031700A (en) Method of treating fibrosis
AU2002243920A1 (en) Methods and compounds for treating neurologic or neuropsychiatric disorders and identifying compounds to treat the same